(19)
(11) EP 2 485 690 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.03.2017 Bulletin 2017/11

(45) Mention of the grant of the patent:
26.10.2016 Bulletin 2016/43

(21) Application number: 10757690.2

(22) Date of filing: 16.09.2010
(51) International Patent Classification (IPC): 
A61F 6/22(2006.01)
(86) International application number:
PCT/US2010/049186
(87) International publication number:
WO 2011/043909 (14.04.2011 Gazette 2011/15)

(54)

APPARATUS FOR ENDOMETRIAL ABLATION IN COMBINATION WITH INTRAFALLOPIAN CONTRACEPTIVE DEVICES

VORRICHTUNG FÜR ENDOMETRIALE ABLATION IN KOMBINAITON MIT EILEITER-VERHÜTUNGSMITTELN

APPAREIL POUR ABLATION DE L'ENDOMÈTRE EN COMBINAISON AVEC DES DISPOSITIFS CONTRACEPTIFS INTRAFALLOPIENS

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 09.10.2009 US 577112

(43) Date of publication of application:
15.08.2012 Bulletin 2012/33

(73) Proprietor: Bayer Essure Inc.
Whippany, NJ 07981 (US)

(72) Inventor:
  • SWANN, Betsy
    Grass Valley CA 95945 (US)

(74) Representative: BIP Patents 
c/o Bayer Intellectual Property GmbH Alfred-Nobel-Straße 10
40789 Monheim am Rhein
40789 Monheim am Rhein (DE)


(56) References cited: : 
US-A1- 2005 182 397
US-A1- 2008 154 256
 US-A1- 2005 274 384
US-A1- 2009 056 722
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).